These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 16462096)
41. Discovery and characterization of endogenous cannabinoids. Martin BR; Mechoulam R; Razdan RK Life Sci; 1999; 65(6-7):573-95. PubMed ID: 10462059 [TBL] [Abstract][Full Text] [Related]
42. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053 [TBL] [Abstract][Full Text] [Related]
43. 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex. Almeida-Santos AF; Moreira FA; Guimaraes FS; Aguiar DC J Psychopharmacol; 2017 Jun; 31(6):740-749. PubMed ID: 28440729 [TBL] [Abstract][Full Text] [Related]
44. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859 [TBL] [Abstract][Full Text] [Related]
45. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. Chiba T; Ueno S; Obara Y; Nakahata N J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165 [TBL] [Abstract][Full Text] [Related]
46. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Bisogno T; MacCarrone M; De Petrocellis L; Jarrahian A; Finazzi-Agrò A; Hillard C; Di Marzo V Eur J Biochem; 2001 Apr; 268(7):1982-9. PubMed ID: 11277920 [TBL] [Abstract][Full Text] [Related]
47. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. De Petrocellis L; Melck D; Palmisano A; Bisogno T; Laezza C; Bifulco M; Di Marzo V Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8375-80. PubMed ID: 9653194 [TBL] [Abstract][Full Text] [Related]
48. Anandamide hydrolysis: a new target for anti-anxiety drugs? Gaetani S; Cuomo V; Piomelli D Trends Mol Med; 2003 Nov; 9(11):474-8. PubMed ID: 14604824 [TBL] [Abstract][Full Text] [Related]
49. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. Lee M; Yang KH; Kaminski NE J Pharmacol Exp Ther; 1995 Nov; 275(2):529-36. PubMed ID: 7473135 [TBL] [Abstract][Full Text] [Related]
50. Targeting the cannabinoid system for pain relief? Chiou LC; Hu SS; Ho YC Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672 [TBL] [Abstract][Full Text] [Related]
51. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. Darmani NA J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094 [TBL] [Abstract][Full Text] [Related]
52. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. Di Marzo V Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065 [TBL] [Abstract][Full Text] [Related]
53. Is GPR55 an anandamide receptor? Brown AJ; Robin Hiley C Vitam Horm; 2009; 81():111-37. PubMed ID: 19647110 [TBL] [Abstract][Full Text] [Related]
54. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. Thiemann G; van der Stelt M; Petrosino S; Molleman A; Di Marzo V; Hasenöhrl RU Behav Brain Res; 2008 Mar; 187(2):289-96. PubMed ID: 17988751 [TBL] [Abstract][Full Text] [Related]
55. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629 [TBL] [Abstract][Full Text] [Related]
56. The endocannabinoid system: physiology and pharmacology. Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444 [TBL] [Abstract][Full Text] [Related]
57. The endogenous cannabinoid system and the treatment of marijuana dependence. Piomelli D Neuropharmacology; 2004; 47 Suppl 1():359-67. PubMed ID: 15464150 [TBL] [Abstract][Full Text] [Related]
58. Acute neuronal injury, excitotoxicity, and the endocannabinoid system. van der Stelt M; Veldhuis WB; Maccarrone M; Bär PR; Nicolay K; Veldink GA; Di Marzo V; Vliegenthart JF Mol Neurobiol; 2002; 26(2-3):317-46. PubMed ID: 12428763 [TBL] [Abstract][Full Text] [Related]
59. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718 [TBL] [Abstract][Full Text] [Related]
60. Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. Oka S; Yanagimoto S; Ikeda S; Gokoh M; Kishimoto S; Waku K; Ishima Y; Sugiura T J Biol Chem; 2005 May; 280(18):18488-97. PubMed ID: 15749716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]